These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28993650)

  • 1. Development of A Machine Learning Algorithm to Classify Drugs Of Unknown Fetal Effect.
    Boland MR; Polubriaginof F; Tatonetti NP
    Sci Rep; 2017 Oct; 7(1):12839. PubMed ID: 28993650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug use during pregnancy and breast-feeding. A classification system for drug information.
    Berglund F; Flodh H; Lundborg P; Prame B; Sannerstedt R
    Acta Obstet Gynecol Scand Suppl; 1984; 126():1-55. PubMed ID: 6393685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal health status prediction based on maternal clinical history using machine learning techniques.
    Akbulut A; Ertugrul E; Topcu V
    Comput Methods Programs Biomed; 2018 Sep; 163():87-100. PubMed ID: 30119860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs during pregnancy: an issue of risk classification and information to prescribers.
    Sannerstedt R; Lundborg P; Danielsson BR; Kihlström I; Alván G; Prame B; Ridley E
    Drug Saf; 1996 Feb; 14(2):69-77. PubMed ID: 8852521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk classification systems for drug use during pregnancy: are they a reliable source of information?
    Addis A; Sharabi S; Bonati M
    Drug Saf; 2000 Sep; 23(3):245-53. PubMed ID: 11005706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duloxetine and pregnancy outcomes: safety surveillance findings.
    Hoog SL; Cheng Y; Elpers J; Dowsett SA
    Int J Med Sci; 2013; 10(4):413-9. PubMed ID: 23471302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning algorithms to predict early pregnancy loss after in vitro fertilization-embryo transfer with fetal heart rate as a strong predictor.
    Liu L; Jiao Y; Li X; Ouyang Y; Shi D
    Comput Methods Programs Biomed; 2020 Nov; 196():105624. PubMed ID: 32623348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing paradigms in detecting rare adverse drug reactions: from disproportionality analysis, old and new, to machine learning.
    Arku D; Yousef C; Abraham I
    Expert Opin Drug Saf; 2022 Oct; 21(10):1235-1238. PubMed ID: 36181369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human experiences related to adverse drug reactions to the fetus or neonate from some maternally administered drugs.
    Shirkey HC
    Adv Exp Med Biol; 1972; 27():17-30. PubMed ID: 4140679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PregTox: A Resource of Knowledge about Drug Fetal Toxicity.
    Chen Q; Gan Y; Wang K; Li Q
    Biomed Res Int; 2022; 2022():4284146. PubMed ID: 35469349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Fetal Alcohol Spectrum Disorders Using Machine Learning Techniques: Multisite Retrospective Cohort Study.
    Oh SS; Kuang I; Jeong H; Song JY; Ren B; Moon JY; Park EC; Kawachi I
    J Med Internet Res; 2023 Jul; 25():e45041. PubMed ID: 37463016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an automated assessment tool for MedWatch reports in the FDA adverse event reporting system.
    Han L; Ball R; Pamer CA; Altman RB; Proestel S
    J Am Med Inform Assoc; 2017 Sep; 24(5):913-920. PubMed ID: 28371826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smallpox vaccination and adverse reactions. Guidance for clinicians.
    Cono J; Casey CG; Bell DM;
    MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern Recognition and Anomaly Detection in fetal morphology using Deep Learning and Statistical learning (PARADISE): protocol for the development of an intelligent decision support system using fetal morphology ultrasound scan to detect fetal congenital anomaly detection.
    Belciug S; Ivanescu RC; Serbanescu MS; Ispas F; Nagy R; Comanescu CM; Istrate-Ofiteru A; Iliescu DG
    BMJ Open; 2024 Feb; 14(2):e077366. PubMed ID: 38365300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data mining in pharmacovigilance--detecting the unexpected: the role of index of suspicion of the reporter.
    Sundström A; Hallberg P
    Drug Saf; 2009; 32(5):419-27. PubMed ID: 19419236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating drug repositioning opportunities in FDA drug labels through topic modeling.
    Bisgin H; Liu Z; Kelly R; Fang H; Xu X; Tong W
    BMC Bioinformatics; 2012; 13 Suppl 15(Suppl 15):S6. PubMed ID: 23046522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug use in pregnancy: how to avoid problems.
    Rao JM; Arulappu R
    Drugs; 1981 Nov; 22(5):409-14. PubMed ID: 6120825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of follow-up standard sonography for fetal anomaly detection.
    Byrne JJ; Morgan JL; Twickler DM; McIntire DD; Dashe JS
    Am J Obstet Gynecol; 2020 Jun; 222(6):615.e1-615.e9. PubMed ID: 31930994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription of hazardous drugs during pregnancy.
    Malm H; Martikainen J; Klaukka T; Neuvonen PJ
    Drug Saf; 2004; 27(12):899-908. PubMed ID: 15366977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.